BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.300
-0.210 (-4.66%)
At close: Apr 28, 2026, 4:00 PM EDT
4.622
+0.322 (7.49%)
After-hours: Apr 28, 2026, 6:39 PM EDT
BioAtla Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 2 | 11 | - | - | 0.25 | |
| Revenue Growth (YoY) | -81.82% | - | - | - | -41.73% | |
| Cost of Revenue | 43.07 | 63.1 | 103.73 | 79.35 | 58.27 | |
| Gross Profit | -41.07 | -52.1 | -103.73 | -79.35 | -58.02 | |
| Selling, General & Admin | 17.63 | 21.85 | 25.96 | 28.79 | 38.42 | |
| Operating Expenses | 17.63 | 21.85 | 25.96 | 28.79 | 38.42 | |
| Operating Income | -58.71 | -73.94 | -129.69 | -108.14 | -96.44 | |
| Interest Expense | - | - | - | - | -0 | |
| Interest & Investment Income | 0.84 | 3.37 | 6.31 | 1.65 | 0.35 | |
| Other Non Operating Income (Expenses) | -1.15 | 0.8 | -0.09 | 0.01 | 0 | |
| EBT Excluding Unusual Items | -59.01 | -69.78 | -123.46 | -106.48 | -96.09 | |
| Merger & Restructuring Charges | -0.6 | - | - | - | - | |
| Other Unusual Items | - | - | - | - | 0.69 | |
| Pretax Income | -59.61 | -69.78 | -123.46 | -106.48 | -95.4 | |
| Earnings From Continuing Operations | -59.61 | -69.78 | -123.46 | -106.48 | -95.4 | |
| Net Income | -59.61 | -69.78 | -123.46 | -106.48 | -95.4 | |
| Net Income to Common | -59.61 | -69.78 | -123.46 | -106.48 | -95.4 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | |
| Shares Change (YoY) | 21.11% | 1.67% | 22.73% | 12.63% | 310.07% | |
| EPS (Basic) | -50.66 | -71.83 | -129.21 | -136.77 | -138.02 | |
| EPS (Diluted) | -50.66 | -71.83 | -129.21 | -136.77 | -138.02 | |
| Free Cash Flow | -48.2 | -71.94 | -104.11 | -90.69 | -63.14 | |
| Free Cash Flow Per Share | -40.97 | -74.05 | -108.96 | -116.48 | -91.34 | |
| Operating Margin | -2935.25% | -672.21% | - | - | -38576.00% | |
| Profit Margin | -2980.35% | -634.33% | - | - | -38160.80% | |
| Free Cash Flow Margin | -2410.20% | -653.96% | - | - | -25255.20% | |
| EBITDA | -58.33 | -73.02 | -128.47 | -106.94 | -95.11 | |
| D&A For EBITDA | 0.37 | 0.93 | 1.22 | 1.2 | 1.33 | |
| EBIT | -58.71 | -73.94 | -129.69 | -108.14 | -96.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.